1. Home
  2. NVST vs APLS Comparison

NVST vs APLS Comparison

Compare NVST & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVST
  • APLS
  • Stock Information
  • Founded
  • NVST 2018
  • APLS 2009
  • Country
  • NVST United States
  • APLS United States
  • Employees
  • NVST N/A
  • APLS N/A
  • Industry
  • NVST Medical/Dental Instruments
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVST Health Care
  • APLS Health Care
  • Exchange
  • NVST Nasdaq
  • APLS Nasdaq
  • Market Cap
  • NVST 3.3B
  • APLS 3.3B
  • IPO Year
  • NVST 2019
  • APLS 2017
  • Fundamental
  • Price
  • NVST $15.18
  • APLS $18.20
  • Analyst Decision
  • NVST Hold
  • APLS Buy
  • Analyst Count
  • NVST 13
  • APLS 18
  • Target Price
  • NVST $20.54
  • APLS $45.59
  • AVG Volume (30 Days)
  • NVST 4.0M
  • APLS 2.8M
  • Earning Date
  • NVST 05-01-2025
  • APLS 05-06-2025
  • Dividend Yield
  • NVST N/A
  • APLS N/A
  • EPS Growth
  • NVST N/A
  • APLS N/A
  • EPS
  • NVST N/A
  • APLS N/A
  • Revenue
  • NVST $2,510,600,000.00
  • APLS $781,367,000.00
  • Revenue This Year
  • NVST $2.37
  • APLS $12.71
  • Revenue Next Year
  • NVST $3.11
  • APLS $20.93
  • P/E Ratio
  • NVST N/A
  • APLS N/A
  • Revenue Growth
  • NVST N/A
  • APLS 97.02
  • 52 Week Low
  • NVST $14.22
  • APLS $17.49
  • 52 Week High
  • NVST $23.00
  • APLS $53.06
  • Technical
  • Relative Strength Index (RSI)
  • NVST 38.74
  • APLS 28.14
  • Support Level
  • NVST $14.22
  • APLS $18.00
  • Resistance Level
  • NVST $15.84
  • APLS $19.71
  • Average True Range (ATR)
  • NVST 0.96
  • APLS 1.63
  • MACD
  • NVST -0.02
  • APLS -0.16
  • Stochastic Oscillator
  • NVST 27.83
  • APLS 10.98

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: